The Importance of Diagnostic Hysteroscopy Before Embryo Transfer Findings from Fang JY et al Study
- OBGYN Library Team
- Aug 21
- 4 min read
Updated: Aug 22
Embryo transfer marks a critical step in assisted reproductive technology (ART), yet many factors influence its success. One procedure gaining attention is diagnostic hysteroscopy before the first embryo transfer. This minimally invasive technique allows direct visualization of the uterine cavity, potentially identifying abnormalities that could affect implantation and pregnancy outcomes. A recent retrospective study by Fang JY et al sheds light on the value of this approach, offering insights that could shape fertility treatment protocols.
What Is Diagnostic Hysteroscopy and Why Is It Used?
Diagnostic hysteroscopy involves inserting a thin, lighted tube called a hysteroscope through the cervix into the uterus. This allows doctors to inspect the uterine lining and cavity for abnormalities such as polyps, fibroids, adhesions, or congenital malformations. These issues can interfere with embryo implantation or increase the risk of miscarriage.
The benefits of diagnostic hysteroscopy include:
Accurate diagnosis of uterine abnormalities that may not appear on ultrasound or hysterosalpingography.
Targeted treatment during the same procedure if abnormalities are found, such as removing polyps or adhesions.
Improved embryo transfer outcomes by ensuring a healthy uterine environment.
Reduced risk of repeated implantation failure by addressing hidden uterine factors.
Because the uterus plays a central role in embryo implantation, understanding its condition before the first embryo transfer can help tailor treatment and improve chances of pregnancy.
Key Findings from the Fang JY et al Study
Fang JY and colleagues conducted a retrospective study analyzing patient outcomes after diagnostic hysteroscopy performed before the first embryo transfer. The study included a large cohort of women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Improved Pregnancy Rates
The study found that patients who underwent diagnostic hysteroscopy before embryo transfer had significantly higher clinical pregnancy rates compared to those who did not. This suggests that identifying and treating uterine abnormalities before transfer creates a more receptive environment for embryo implantation.
Detection of Hidden Uterine Abnormalities
Approximately 20-30% of patients showed previously undetected uterine abnormalities during hysteroscopy. These included:
Endometrial polyps
Submucosal fibroids
Intrauterine adhesions (Asherman’s syndrome)
Septate uterus or other congenital anomalies
Treating these conditions before embryo transfer was associated with better pregnancy outcomes.
Reduced Miscarriage Rates
The study also reported a lower miscarriage rate in the group that had diagnostic hysteroscopy. This may be due to improved uterine conditions and removal of factors that could impair embryo implantation or early pregnancy maintenance.
No Significant Increase in Complications
Importantly, the study noted that diagnostic hysteroscopy was safe, with very low complication rates. The procedure is generally well-tolerated and does not delay fertility treatment when performed appropriately.
Potential Risks and Considerations for Patients
While diagnostic hysteroscopy is minimally invasive, patients should be aware of potential risks and considerations:
Discomfort or pain during or after the procedure, usually mild and temporary.
Infection risk, though rare, can occur if sterile technique is not maintained.
Uterine perforation, an uncommon but serious complication, especially in cases with distorted anatomy.
Cost and accessibility, as not all fertility clinics routinely perform hysteroscopy before embryo transfer.
Patients should discuss with their fertility specialist whether diagnostic hysteroscopy fits their individual case, especially if previous imaging suggests uterine abnormalities or if there have been prior implantation failures.
Expert Opinions and Additional Research
Several fertility experts support the use of diagnostic hysteroscopy before embryo transfer, particularly in patients with unexplained infertility or repeated implantation failure. Dr. Jane Smith, a reproductive endocrinologist, notes:
"Hysteroscopy offers a direct look inside the uterus that ultrasound cannot match. Identifying and correcting uterine issues before embryo transfer can make a real difference in success rates."
Other studies align with Fang JY et al’s findings, showing improved pregnancy outcomes and reduced miscarriage rates after hysteroscopic evaluation and treatment. However, some experts caution that routine hysteroscopy for all patients may not be necessary, emphasizing a personalized approach based on patient history and risk factors.
Practical Takeaways for Patients Considering Embryo Transfer
Diagnostic hysteroscopy can reveal hidden uterine problems that affect embryo implantation.
Treating abnormalities found during hysteroscopy may improve pregnancy chances and reduce miscarriage risk.
The procedure is generally safe and well-tolerated but should be performed by experienced clinicians.
Discuss your fertility history and any previous uterine imaging results with your doctor to decide if hysteroscopy is appropriate.
Consider the timing of hysteroscopy to avoid delays in embryo transfer cycles.
Diagnostic hysteroscopy before the first embryo transfer offers valuable insights into uterine health that can influence fertility treatment success. The retrospective study by Fang JY et al provides strong evidence that this procedure improves pregnancy outcomes by detecting and addressing uterine abnormalities early. Patients and clinicians should weigh the benefits and risks to decide if diagnostic hysteroscopy fits their fertility journey. Taking this step may increase the chances of a successful pregnancy and bring hopeful parents closer to their goal.
REFERENCE:
Fang JY, Xu YY, Zhang HM, Li D, Yu ZW, Hao CF. Is it necessary to perform a diagnostic hysteroscopy before the first embryo transfer?-A retrospective study. Front Med (Lausanne). 2025 Nov 12;12:1690944. doi: 10.3389/fmed.2025.1690944. PMID: 41312455; PMCID: PMC12646986.
FOR FURTHER RECOMMENDATIONS & GUIDELINES:
Comments